Skip to main content
. 2023 May 17;55(4):1104–1112. doi: 10.4143/crt.2023.502

Table 4.

Incidence of treatment-related adverse events

Any grade Grade 3–4
Alopecia 1 (3.2) 0
Anemia 0 1 (3.2)
Anorexia 5 (16.1) 0
Arrhythmia 1 (3.2) 0
Bleeding 2 (6.5) 0
Constipation 2 (6.5) 1 (3.2)
Cough 1 (3.2) 0
Diarrhea 4 (12.9) 0
Dyspnea 4 (12.9) 0
Electrolyte imbalance 6 (19.4) 2 (6.5)
Elevated amylase/lipase 1 (3.2) 0
Epigastric pain 1 (3.2) 0
Fatigue 2 (3.2) 0
Fever 3 (9.7) 0
Headache 2 (6.5) 0
Hyperglycemia 1 (3.2) 1 (3.2)
Hypothyroidism 4 (12.9) 0
Insomnia 3 (9.7) 0
Infusion-related reaction 4 (12.9) 0
Intraocular problem 1 (3.2) 0
Otitis 1 (3.2) 0
Pneumonia 5 (16.1) 1 (3.2)
Pruritus 3 (9.7) 0
Nausea 5 (16.1) 0
Rash 6 (19.4) 0
Seizure 1 (3.2) 0
Stomatitis 4 (12.9) 0
Thrombosis 1 (3.2) 0
Worsening of cancer pain 2 (6.5) 0

Values are presented as number (%).